seekingalpha.com · 3 jul

Park Hotels & Resorts: This Rally May Not Be Over

Park Hotels & Resorts remains a Buy, offering a compelling margin of safety and attractive valuation despite a 30% stock rally. Q1 results exceeded expectations, with RevPAR up 2.2% YoY, and ongoing renovations are expected to drive further improvements later on. PK's disciplined asset sales and portfolio optimization strengthen its balance sheet amid elevated leverage and support their renovations, offering a well-covered 7% dividend yield.

businesswire.com · 23 jun

Javelin Biotech and Pfizer Announce Landmark Publication Demonstrating Clinical PK Predictions Using Multi-Tissue Chip Platform

BILLERICA, Mass.--(BUSINESS WIRE)--Javelin Biotech today announced a landmark scientific publication, titled "Interconnected multi-microphysiological systems and PBPK modeling for predicting human pharmacokinetics”, in the "Breakthrough" special issue of Lab on a Chip. The study details a liver-centric multi-tissue chip (MTC) platform designed to capture the complex pharmacokinetic (PK) profiles of small-molecule drugs. The research marks a significant demonstration of how combinatorial NAMs en.

247wallst.com · 18 jun

KBWY Up 20% This Year, But The Real Test Comes When Rent Rolls Reset

Income hunters know Invesco KBW Premium Yield Equity REIT ETF (NASDAQ:KBWY) as one of the highest-yielding equity REIT funds on the market, with a 30-day SEC yield of 8.26% and a 12-month distribution rate of 8.6%.

marketbeat.com · 18 jun

3 Hotel REITs Poised to Benefit from the World Cup

The FIFA World Cup 2026 is underway, and outside of the competition on the pitch, the competition for consumer dollars may be equally intense. Official estimates forecast U.S. accommodations and food services generating over $2.4 billion in incremental economic value from the tournament.

seekingalpha.com · 18 jun

Park Hotels & Resorts Gets An Upgrade As It Invests In Upgrading Portfolio

I am upgrading Park Hotels & Resorts to a buy, driven by strong market momentum, property upgrades, and resilient top-line growth. PK demonstrates competitive positioning with a focus on upper-upscale renovations, notably achieving +27% group revenue growth at the Royal Palm South Beach. Despite volatile FFO and high leverage, PK offers a safe, elevated dividend yield (~6.8%) with solid coverage, though dividend growth is muted.

zacks.com · 11 jun

Are Investors Undervaluing Park Hotels & Resorts (PK) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

gurufocus.com · 11 jun

Hyundai Bioscience USA offers Free Drug Supply and Funding for Clinical Trials to WHO

Hyundai Bioscience USA offers Free Drug Supply and Funding for Clinical Trials to WHO PR Newswire SAN JOSE, Cali

gurufocus.com · 9 jun

PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers

[url="]PureTech Health plc[/url] (LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and tra